Great find Natasa!
Natasa, this is brilliant news!
Dr. Mikovits has been invited to present data pertaining to prostate cancer and ME/CFS at the 50th British Society of Hematology scientific meeting next month.
Will this be data from the Robert Koch re-tested prostate patients?
Remember Dr Mikovits was collaborating with Bannert's German prostate cancer research team from the Robert Koch Institute (the folks who did not find XMRV in some 600 prostate ca patients)? From what I vaguely recall, the Bannert prostate paper was already in the works when the
Science paper came out. After Oct 8th, Bannert and WPI agreed to collaborate, to retest the hitherto XMRV-negative German prostate patients with WPI's assistance. And we eagerly await the results... Geez, this could blow those weak "XMRV non-replication" studies out of the water! While the scientists unable to find XMRV in ME/CFS patients have been griping at the WPI, the WPI has been quietly collaborating with other negative studies - notably Bannerts - to assist them in their lab methods to find XMRV. Kudos to Bannert's team for their genuine scientific curiosity to find out: were their methods sufficient to find XMRV?
Based on the intense interest in XMRV and prostate cancer at the Conference on Retroviral and Opportunistic Infections and other recent venues, I wouldn't be surprised if there is yet more corroboration in the pipe that indeed Mikovits, Silverman, Singh, etc are the gurus to understand just how to isolate this virus in prostate cancer - and oh yes, ME/CFS - patients.
So... the million-dollar question is: Will this be new WPI data presented? In which case, can we expect another publication from WPI soon? Anyone know?
Now I gotta ask my globe-trotting hematologist whether he'll be @ that conference. I feel like a dog who just found a muddy bone in the dirt! Pant, pant.:Retro smile: